These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1701642)

  • 1. Individual NK cell clones lyse both tumor cell targets and herpes simplex virus-infected fibroblasts in the absence of interferon.
    Canessa A; Chatterjee S; Whitley RJ; Prasthofer EF; Grossi CE; Tilden AB
    Viral Immunol; 1990; 3(3):217-24. PubMed ID: 1701642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
    Colmenares C; Lopez C
    J Immunol; 1986 May; 136(9):3473-80. PubMed ID: 2420891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity amongst natural killer cells revealed by limiting dilution culture; selectivity against virus-infected and tumour cell targets.
    Mason PD; Sissons JG; Borysiewicz LK
    Immunology; 1993 Dec; 80(4):625-32. PubMed ID: 8307613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positively selected Leu-11a (CD16+) cells require the presence of accessory cells or factors for the lysis of herpes simplex virus-infected fibroblasts but not herpes simplex virus-infected Raji.
    Fitzgerald-Bocarsly P; Feldman M; Curl S; Schnell J; Denny T
    J Immunol; 1989 Aug; 143(4):1318-26. PubMed ID: 2526183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cells lyse autologous herpes simplex virus infected targets using cytolytic mechanisms distributed clonotypically.
    Pietra G; Semino C; Cagnoni F; Boni L; Cangemi G; Frumento G; Melioli G
    J Med Virol; 2000 Nov; 62(3):354-63. PubMed ID: 11055246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer-mediated lysis of some but not all HSV-1- or VSV-infected targets requires the participation of HLA-DR-positive accessory cells.
    Howell DM; Fitzgerald-Bocarsly P
    Immunology; 1991 Mar; 72(3):443-7. PubMed ID: 1851136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative mechanisms of natural killer cell activation during herpes simplex virus infection.
    Paya CV; Schoon RA; Leibson PJ
    J Immunol; 1990 Jun; 144(11):4370-5. PubMed ID: 2160501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of human NK cells: comparison of effectors that lyse HSV-1-infected fibroblasts and K562 erythroleukemia targets.
    Fitzgerald PA; Evans R; Kirkpatrick D; Lopez C
    J Immunol; 1983 Apr; 130(4):1663-7. PubMed ID: 6601135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer cellular cytotoxicity against herpes simplex virus-infected cells in Igh-1-disparate mice.
    Tamesis RR; Foster CS
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2224-9. PubMed ID: 1700771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human natural killer cells limit replication of herpes simplex virus type 1 in vitro.
    Fitzgerald PA; Mendelsohn M; Lopez C
    J Immunol; 1985 Apr; 134(4):2666-72. PubMed ID: 2982949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysis of human cytomegalovirus infected fibroblasts by natural killer cells: demonstration of an interferon-independent component requiring expression of early viral proteins and characterization of effector cells.
    Borysiewicz LK; Rodgers B; Morris S; Graham S; Sissons JG
    J Immunol; 1985 Apr; 134(4):2695-701. PubMed ID: 2579152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperation between CD16(Leu-11b)+ NK cells and HLA-DR+ cells in natural killing of herpesvirus-infected fibroblasts.
    Oh SH; Bandyopadhyay S; Miller DS; Starr SE
    J Immunol; 1987 Oct; 139(8):2799-802. PubMed ID: 2821120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of herpes simplex virus on induced cell-mediated cytotoxicity in neonates and adults.
    Chin TW; Plaeger-Marshall S; Ank BJ; Pressman SR; Stiehm ER
    Nat Immun Cell Growth Regul; 1991; 10(5):237-46. PubMed ID: 1661847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
    J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional heterogeneity among herpes simplex virus-specific human CD4+ T cells.
    Yasukawa M; Inatsuki A; Horiuchi T; Kobayashi Y
    J Immunol; 1991 Feb; 146(4):1341-7. PubMed ID: 1671404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human newborn natural killer cell responses to activation by monoclonal antibodies. Effect of culture with herpes simplex virus.
    Hayward A; Laszlo M; Vafai A
    J Immunol; 1989 Feb; 142(4):1139-43. PubMed ID: 2536766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of interferon in natural kill of HSV-1-infected fibroblasts.
    Fitzgerald PA; von Wussow P; Lopez C
    J Immunol; 1982 Aug; 129(2):819-23. PubMed ID: 6177785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) cultures.
    Atzpodien J; Wisniewski D; Gulati S; Welte K; Knowles R; Clarkson B
    Nat Immun Cell Growth Regul; 1987; 6(3):129-40. PubMed ID: 3114621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of human natural killer cells by herpes simplex virus type 1-infected cells.
    Bishop GA; McCurry L; Schwartz SA; Glorioso JC
    Intervirology; 1987; 28(2):78-88. PubMed ID: 2832348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of interferon in human natural killer activity against target cells infected with HSV-1.
    Bishop GA; Glorioso JC; Schwartz SA
    J Immunol; 1983 Oct; 131(4):1849-53. PubMed ID: 6194217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.